Categories
Piramal Pharma Limited — Credit Ratings, 22-10-2024: Credit Rating- New
22-10-2024 · 03:25 pm
Piramal Pharma Limited announced that ICRA Limited has assigned an A1+ rating to its prospective commercial paper. This rating reflects the company's strong creditworthiness and ability to meet short-term financial obligations. Investors can view this development as a positive indicator of the company's financial health.
No comments yet. Be the first to comment!